Related Experiment Video
Updated: Mar 13, 2026

17:59
Derivation of Thymic Lymphoma T-cell Lines from Atm-/- and p53-/- Mice
Published on: April 3, 2011
12.8K
Somatic and germline genomic variation in thymic carcinomas
F Tettamanzi1, C De Carlo2, C Cappadona1
1IRCCS Humanitas Research Hospital, Milan, Italy.
ESMO Open
|March 11, 2026
Summary
Thymic carcinoma (TC) is genomically diverse. DNA damage response gene mutations impact overall survival and may indicate response to targeted therapies, highlighting new prognostic and therapeutic avenues.
Area of Science:
- Oncology
- Genomics
- Cancer Research
Background:
- Thymic carcinoma (TC) is a rare, aggressive cancer.
- Currently, no biomarkers exist to guide TC treatment or prognosis.
Purpose of the Study:
- To characterize the genomic landscape of thymic carcinoma.
- To identify potential biomarkers for treatment and prognosis.
Main Methods:
- Whole-exome sequencing of 25 TC samples and 17 adjacent normal tissues.
- Analysis of somatic and germline genomic alterations.
- Association of genomic characteristics with clinical outcomes.
Main Results:
- High tumor mutational burden (TMB) and microsatellite instability observed in 8% and ~30% of cases, respectively.
- Somatic mutations in DNA damage response (DDR) genes linked to high TMB and worse overall survival (OS).
- ~30% of patients had mutations suggesting response to poly (ADP-ribose) polymerase inhibitors.
Conclusions:
- Thymic carcinoma is a heterogeneous disease with varying genomic alteration rates.
- Identified somatic and germline aberrations warrant further investigation for prognostic and clinical implications.
- Genomic characterization offers potential for novel therapeutic strategies in TC.
Related Concept Videos
Cancers Originate from Somatic Mutations in a Single Cell
15.3K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
15.3K
Cancers Originate from Somatic Mutations in a Single Cell
3.1K
3.1K
Cancer-Critical Genes II: Tumor Suppressor Genes
2.9K
2.9K
Cancer-Critical Genes II: Tumor Suppressor Genes
10.0K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
10.0K
Tumor Progression
7.7K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.7K
Mutations
45.1K
Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
45.1K

